Dana Holger
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Resistance in Bacteria 14
-
- Antimicrobial Resistance in Staphylococcus 7
- Co-authors
- Ashlan J. Kunz Coyne (16 shared papers)Amer El Ghali (11 shared papers)Nicholas Rebold (9 shared papers)Michael J. Rybak (4 shared papers)Michael J. Rybak (17 shared papers)Taylor Morrisette (14 shared papers)Razieh Kebriaei (10 shared papers)Jaime L. Tartar (1 shared paper)
- Journals
- Open Forum Infectious Diseases (6 papers)Infectious Diseases and Therapy (4 papers)Microbiology Spectrum (4 papers)Antimicrobial Agents and Chemotherapy (3 papers)Antibiotics (3 papers)
- Partner nations
- United StatesSaudi Arabia
In The Last Decade
Dana Holger
24 papers receiving 520 citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Applied Microbiology and Biotechnology 99
- Molecular Medicine 224
- Microbiology 96
- Endocrinology 38
- Ecology 158
Countries citing papers authored by Dana Holger
This map shows the geographic impact of Dana Holger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dana Holger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dana Holger more than expected).
Fields of papers citing papers by Dana Holger
This network shows the impact of papers produced by Dana Holger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dana Holger. The network helps show where Dana Holger may publish in the future.
Co-authors
The 25 scholars most cited alongside Dana Holger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa Hit paper breakdown → | 2022 | 162 |
| 2 | 2017 | 77 | |
| 3 | 2022 | 31 | |
| 4 | 2022 | 30 | |
| 5 | 2023 | 28 | |
| 6 | 2021 | 24 | |
| 7 | 2021 | 23 | |
| 8 | 2022 | 23 | |
| 9 | 2022 | 21 | |
| 10 | 2022 | 18 | |
| 11 | 2023 | 18 | |
| 12 | 2023 | 15 | |
| 13 | 2023 | 14 | |
| 14 | 2022 | 10 | |
| 15 | 2021 | 9 | |
| 16 | 2024 | 7 | |
| 17 | 2023 | 6 | |
| 18 | 2024 | 6 | |
| 19 | 2022 | 5 | |
| 20 | 2023 | 4 |
About Dana Holger
Dana Holger is a scholar working on Molecular Medicine, Infectious Diseases, Ecology, Pharmacology and Epidemiology, having authored 27 papers that have together received 538 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (14 papers), Bacteriophages and microbial interactions (9 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers), Antimicrobial Resistance in Staphylococcus (7 papers), Antibiotic Use and Resistance (5 papers), Microbial infections and disease research (5 papers), Pharmacovigilance and Adverse Drug Reactions (2 papers) and Bacterial Genetics and Biotechnology (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (99 citations), Molecular Medicine (224 citations), Microbiology (96 citations), Endocrinology (38 citations) and Ecology (158 citations). Dana Holger has collaborated with scholars based in United States and Saudi Arabia. Frequent co-authors include Ashlan J. Kunz Coyne, Amer El Ghali, Nicholas Rebold, Michael J. Rybak, Michael J. Rybak, Taylor Morrisette, Razieh Kebriaei, Jaime L. Tartar, Katherine L. Lev and Malav Trivedi. Their work appears in journals such as Open Forum Infectious Diseases, Infectious Diseases and Therapy, Microbiology Spectrum, Antimicrobial Agents and Chemotherapy and Antibiotics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.